The experience of use of everolimus in patients having undergone to orthotopic liver transplantation

The efficacy and safety of everolimus in 10 recipients of liver in the post-transplant period with simultaneous reducing the dose of calcineurin inhibitors are analyzed. After conversion of immunosuppression the duration of monitoring of patients ranged from 4 to 18 months. Episodes of acute cellula...

Full description

Bibliographic Details
Main Authors: V. E. Syutkin, O. I. Andreytseva, V. P. Nikulina, A. O. Chugunov
Format: Article
Language:English
Published: N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2018-08-01
Series:Трансплантология (Москва)
Subjects:
Online Access:https://www.jtransplantologiya.ru/jour/article/view/373
_version_ 1797702964249362432
author V. E. Syutkin
O. I. Andreytseva
V. P. Nikulina
A. O. Chugunov
author_facet V. E. Syutkin
O. I. Andreytseva
V. P. Nikulina
A. O. Chugunov
author_sort V. E. Syutkin
collection DOAJ
description The efficacy and safety of everolimus in 10 recipients of liver in the post-transplant period with simultaneous reducing the dose of calcineurin inhibitors are analyzed. After conversion of immunosuppression the duration of monitoring of patients ranged from 4 to 18 months. Episodes of acute cellular rejection were not observed. Already in the first month after inclusion of everolimus in the scheme of immunosuppressive therapy, there was observed an improvement in renal function, which persisted at follow-up of patients. No serious adverse events were observed.
first_indexed 2024-03-12T04:57:34Z
format Article
id doaj.art-466d7fab492647a7bbd596a22b0d411e
institution Directory Open Access Journal
issn 2074-0506
2542-0909
language English
last_indexed 2024-03-12T04:57:34Z
publishDate 2018-08-01
publisher N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
record_format Article
series Трансплантология (Москва)
spelling doaj.art-466d7fab492647a7bbd596a22b0d411e2023-09-03T09:14:38ZengN.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare DepartmentТрансплантология (Москва)2074-05062542-09092018-08-0101-2101410.23873/2074-0506-2012-0-1-2-10-14360The experience of use of everolimus in patients having undergone to orthotopic liver transplantationV. E. Syutkin0O. I. Andreytseva1V. P. Nikulina2A. O. Chugunov3НИИ СП им. Н.В. СклифосовскогоНИИ СП им. Н.В. СклифосовскогоНИИ СП им. Н.В. СклифосовскогоНИИ СП им. Н.В. СклифосовскогоThe efficacy and safety of everolimus in 10 recipients of liver in the post-transplant period with simultaneous reducing the dose of calcineurin inhibitors are analyzed. After conversion of immunosuppression the duration of monitoring of patients ranged from 4 to 18 months. Episodes of acute cellular rejection were not observed. Already in the first month after inclusion of everolimus in the scheme of immunosuppressive therapy, there was observed an improvement in renal function, which persisted at follow-up of patients. No serious adverse events were observed.https://www.jtransplantologiya.ru/jour/article/view/373эверолимустрансплантация печениингибиторы кальциневринапочечная недостаточность
spellingShingle V. E. Syutkin
O. I. Andreytseva
V. P. Nikulina
A. O. Chugunov
The experience of use of everolimus in patients having undergone to orthotopic liver transplantation
Трансплантология (Москва)
эверолимус
трансплантация печени
ингибиторы кальциневрина
почечная недостаточность
title The experience of use of everolimus in patients having undergone to orthotopic liver transplantation
title_full The experience of use of everolimus in patients having undergone to orthotopic liver transplantation
title_fullStr The experience of use of everolimus in patients having undergone to orthotopic liver transplantation
title_full_unstemmed The experience of use of everolimus in patients having undergone to orthotopic liver transplantation
title_short The experience of use of everolimus in patients having undergone to orthotopic liver transplantation
title_sort experience of use of everolimus in patients having undergone to orthotopic liver transplantation
topic эверолимус
трансплантация печени
ингибиторы кальциневрина
почечная недостаточность
url https://www.jtransplantologiya.ru/jour/article/view/373
work_keys_str_mv AT vesyutkin theexperienceofuseofeverolimusinpatientshavingundergonetoorthotopiclivertransplantation
AT oiandreytseva theexperienceofuseofeverolimusinpatientshavingundergonetoorthotopiclivertransplantation
AT vpnikulina theexperienceofuseofeverolimusinpatientshavingundergonetoorthotopiclivertransplantation
AT aochugunov theexperienceofuseofeverolimusinpatientshavingundergonetoorthotopiclivertransplantation
AT vesyutkin experienceofuseofeverolimusinpatientshavingundergonetoorthotopiclivertransplantation
AT oiandreytseva experienceofuseofeverolimusinpatientshavingundergonetoorthotopiclivertransplantation
AT vpnikulina experienceofuseofeverolimusinpatientshavingundergonetoorthotopiclivertransplantation
AT aochugunov experienceofuseofeverolimusinpatientshavingundergonetoorthotopiclivertransplantation